Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute
MVT
Jul 30, 2021
0 min read
top of page
Search
Recent Posts
See AllVeteran family office executive and healthcare investor brings more than 30 years of investment, finance, and board experience.
Experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development
University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location
bottom of page
Comments